Skip to Content
Merck
CN
  • Tuberculous meningoencephalitis in a patient with hairy cell leukemia in complete remission.

Tuberculous meningoencephalitis in a patient with hairy cell leukemia in complete remission.

Journal of clinical and experimental hematopathology : JCEH (2012-06-19)
K Girardi, A Paviglianiti, M Cirillo, A Bianchi, G Gherardi, O Annibali, E Cerchiara, F Marchesi, V Tomarchio, C Miglio, Mc Tirindelli, A Onetti Muda, G Avvisati
ABSTRACT

Tuberculous meningoencephalitis is a rare disease associated with high morbidity and mortality. We report a patient with hairy cell leukemia in complete remission who, after a single cycle of chemotherapy with cladribine, presented fever and neurological deficits. Laboratory diagnosis of tuberculous meningoencephalitis was made by polymerase chain reaction testing for Mycobacterium tuberculosis in cerebrospinal fluid. Despite the prompt institution of antitubercular-therapy, patient's general condition did not improve and he died. Mycobacterial infection should be considered in patients with intra-cranial lesions, affected by hematological malignancies and persistent immunosuppression.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
2-Chloro-2′-deoxyadenosine, antileukemic
Cladribine for peak identification, European Pharmacopoeia (EP) Reference Standard